AKBA — AKEBIA THERAPEUTICS INC

Ownership history in Abel Hall, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Abel Hall, LLC reported a position in AKEBIA THERAPEUTICS INC (AKBA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q2)
Avg. % of fund
0.01%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,500 -118 -1.1% 0.01% $29K $2.73
2025 Q2 INITIATED 10,618 — — 0.02% $39K $3.64
% of Fund (quarterly)    AKBA price (monthly, adj. close)

Other funds also holding AKBA

As of 2025 Q4 — sorted by position size

Nantahala Capital Management, LLC 3Y 7Y 0.11% EntryPoint Capital, LLC 0.08% Orchard Capital Management, LLC 3Y 0.07% OXFORD ASSET MANAGEMENT LLP 3Y 7Y 0.07% nVerses Capital, LLC 0.04% Round Rock Advisors LLC 3Y 0.04% Hennion & Walsh Asset Management, Inc. 3Y 0.03% NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 3Y 7Y 0.02% XTX Topco Ltd 3Y 0.02% Empirical Asset Management, LLC 3Y 0.02%
← Back to Abel Hall, LLC Holdings